Literature DB >> 10781394

Haemodynamic and renal evolution of the bile duct-ligated rat.

C Martínez-Prieto1, M C Ortíz, L A Fortepiani, J Ruiz-Maciá, N M Atucha, J García-Estañ.   

Abstract

In the present study we have characterized the evolution of changes in systemic haemodynamics (thermodilution in conscious animals) and sodium balance (metabolic cages) in a model of liver cirrhosis induced by chronic bile duct ligation (BDL). Mean arterial pressure (BDL, 111.5+/-4.7 mmHg; sham-operated, 122.9+/-3.0 mmHg) and peripheral vascular resistance (BDL, 2.63+/-0.08 units; sham-operated, 2.93+/-0.09 units) were lower in BDL rats from day 12 after surgery and decreased progressively throughout the following days. Portal hypertension was evident earlier in BDL rats and was maintained throughout the study period. Cardiac index (BDL, 58.8+/-3. 9 ml.min(-1).100 g(-1); sham-operated, 43.9+/-1.5 ml.min(-1).100 g(-1)) and stroke volume (BDL, 147.2+/-12.7 ml.beat(-1).100 g(-1); sham-operated, 109.0+/-4.2 ml.beat(-1).100 g(-1)) were significantly elevated in the BDL rats only from day 18 after surgery. There were no significant differences in sodium balance between the groups until day 16 after surgery, at which time BDL animals started to retain significantly more sodium than the controls. Sodium retention increased progressively, and at day 20 BDL rats had retained 0.7 mmol/100 g more than the control animals (accumulated retention: BDL, 2.2+/-0.2 mmol/100 g; sham-operated, 1.5+/-0.2 mmol/100 g). Plasma renin activity and aldosterone concentration were not elevated in the BDL animals at days 12, 16 or 20 after surgery. These data indicate that the BDL rat model shows early portal hypertension, peripheral vasodilation and arterial hypotension, several days before sodium retention is detectable, and in the absence of changes in plasma levels of renin and aldosterone. Overall, these data suggest that, in the BDL rat model, sodium retention is secondary to portal hypertension and peripheral vasodilation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781394

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

Review 1.  Animal models of portal hypertension.

Authors:  Juan-G Abraldes; Marcos Pasarín; Juan-Carlos García-Pagán
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

2.  Activation of RAAS in a rat model of liver cirrhosis: no effect of losartan on renal sodium excretion.

Authors:  A D Fialla; O B Schaffalitzky de Muckadell; P Bie; H C Thiesson
Journal:  BMC Nephrol       Date:  2018-09-19       Impact factor: 2.388

3.  Role of the cytochrome P-450/ epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis.

Authors:  Michael M Yeboah; Md Abdul Hye Khan; Marla A Chesnik; Melissa Skibba; Lauren L Kolb; John D Imig
Journal:  Nephrol Dial Transplant       Date:  2018-08-01       Impact factor: 5.992

4.  Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats.

Authors:  K S Park; Y Li; Y Zhang; A L Gerbes; H Liu; M G Swain; S S Lee
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

5.  Effect of neonatal capsaicin treatment on haemodynamics and renal function in cirrhotic rats.

Authors:  Y Li; D Song; Y Zhang; S S Lee
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.